Literature DB >> 26204989

Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?

Ronald G Schwartz1,2, Nicholas Venci3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26204989     DOI： 10.1007/s12350-015-0194-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  33 in total

1.  Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.

Authors:  Michael S Ewer; Scott M Lippman
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

Review 2.  Trastuzumab-induced cardiac dysfunction.

Authors:  Gurusher Singh Panjrath; Diwakar Jain
Journal:  Nucl Med Commun       Date:  2007-02       Impact factor: 1.690

3.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Authors:  Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; Jose Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez Rovira; Martine J Piccart-Gebhart
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

4.  Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Authors:  Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt
Journal:  Circulation       Date:  2014-11-18       Impact factor: 29.690

Review 5.  ErbB2 pathways in heart and neural diseases.

Authors:  Alistair N Garratt; Cemil Ozcelik; Carmen Birchmeier
Journal:  Trends Cardiovasc Med       Date:  2003-02       Impact factor: 6.677

6.  Effect of anthracycline antibiotics on oxygen radical formation in rat heart.

Authors:  J H Doroshow
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

7.  Anthracycline cardiomyopathy monitored by morphologic changes.

Authors:  M E Billingham; J W Mason; M R Bristow; J R Daniels
Journal:  Cancer Treat Rep       Date:  1978-06

8.  Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.

Authors:  R G Schwartz; W B McKenzie; J Alexander; P Sager; A D'Souza; A Manatunga; P E Schwartz; H J Berger; J Setaro; L Surkin
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

Review 9.  Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.

Authors:  Ronald G Schwartz; Diwakar Jain; Eugene Storozynsky
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

10.  Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.

Authors:  A L Jones; M Barlow; P J Barrett-Lee; P A Canney; I M Gilmour; S D Robb; C J Plummer; A M Wardley; M W Verrill
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640
View more
  2 in total

1.  Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment.

Authors:  Giselle C Meléndez; Bunyapon Sukpraphrute; Ralph B D'Agostino; Jennifer H Jordan; Heidi D Klepin; Leslie Ellis; Zanetta Lamar; Sujethra Vasu; Glenn Lesser; Gregory L Burke; Kathryn E Weaver; William O Ntim; W Gregory Hundley
Journal:  Am J Cardiol       Date:  2017-03-22       Impact factor: 2.778

2.  The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.

Authors:  Raymond R Russell; Jonathan Alexander; Diwakar Jain; Indu G Poornima; Ajay V Srivastava; Eugene Storozynsky; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.